2011
DOI: 10.1159/000322221
|View full text |Cite
|
Sign up to set email alerts
|

Serum Nitrate/Nitrite Concentration Correlates with Gastric Juice Nitrate/Nitrite: A Possible Marker for Mutagenesis of the Proximal Stomach

Abstract: Background/Aims: In the normal acid-secreting stomach, luminally generated nitric oxide, which contributes to carcinogenesis in the proximal stomach, is associated with the concentration of nitrate plus nitrite (nitrate/nitrite) in gastric juice. We investigated whether the serum nitrate/nitrite concentration is associated with that of gastric juice and whether it can be used as a serum marker. Methods: Serum and gastric juice nitrate/nitrite concentration, Helicobacter pylori antibody, and gastric pH were mea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 63 publications
1
8
0
Order By: Relevance
“…From 2007 to 2010, we prospectively enrolled 231 subjects aged 21–86 years who were attending Tokyo Dental College Ichikawa General Hospital outpatient clinic for routine upper gastrointestinal endoscopy. Exclusion criteria were as described previously [18,19]. Gastric mucosal atrophy was diagnosed according to the endoscopic atrophic border scale of Kimura and Takemoto [20]; there were three classifications (1, mild or no atrophy; 2, moderate atrophy; and 3, severe atrophy).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…From 2007 to 2010, we prospectively enrolled 231 subjects aged 21–86 years who were attending Tokyo Dental College Ichikawa General Hospital outpatient clinic for routine upper gastrointestinal endoscopy. Exclusion criteria were as described previously [18,19]. Gastric mucosal atrophy was diagnosed according to the endoscopic atrophic border scale of Kimura and Takemoto [20]; there were three classifications (1, mild or no atrophy; 2, moderate atrophy; and 3, severe atrophy).…”
Section: Methodsmentioning
confidence: 99%
“…Subjects with antibody concentration <10 U/mL were categorized as the infection‐negative group; those with a concentration of 10–30 U/mL were designated the low‐concentration group; those with a concentration of 30–50 U/mL were classified as the moderate‐concentration group; and those with a concentration >50 U/mL were classified as the high‐concentration group. Measurement of serum pepsinogen‐I, pepsinogen‐II, and H. pylori IgG antibodies was contracted out to Mitsubishi Chemical Medience Co., Ltd. (Tokyo, Japan) as described previously [18,19]. Pepsinogen was defined as “atrophic” when the criteria of both pepsinogen‐I < 70 ng/mL and pepsinogen‐I/II ratio <3 were fulfilled [23].…”
Section: Methodsmentioning
confidence: 99%
“…All endoscopies were performed by a single experienced gastroenterologist (HK). Exclusion criteria were as described previously [15,19]. Patients treated with proton pump inhibitors and histamine-2 blockers within 6 months of study enrollment and patients who had received H. pylori eradication therapy were strictly excluded, since proton pump inhibitors and eradication therapy for H. pylori significantly affect serum pepsinogen levels, and thus gastric mucosal atrophy cannot be accurately evaluated by pepsinogen measurement [20].…”
Section: Subjectsmentioning
confidence: 99%
“…Measurement of serum pepsinogen-I, pepsinogen-II and H. pylori IgG antibodies was contracted out to Mitsubishi Chemical Medience Co., Ltd. (Tokyo, Japan) as described previously [15,19]. Subjects with antibody concentrations < 10 U/mL were categorized as infection-negative; those with a concentration ≥ 10 U/mL were designated as +Model CLINRE-548; No.…”
Section: Assays For Antibodies Against H Pylori and For Serum Pepsinmentioning
confidence: 99%
See 1 more Smart Citation